Marianne Gazzano

Case Report: Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifungal Therapy in the Treatment of Refractory Covid-Associated Pulmonary Aspergillosis and Cerebral Mucormycosis

F. Uhel, O. Lambotte, G. Martin-Blondel, 2022, Frontiers in Immunology.

The polarity and specificity of SARS-CoV2 -specific T lymphocyte responses determine disease susceptibility

J. Blay, Benoît R. Kloeckner, L. Zitvogel, 2021, medRxiv.

The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals

J. Blay, Benoît R. Kloeckner, L. Zitvogel, 2022, Cancer discovery.

Escherichia coli-specific CXCL13-producing TFH are associated with clinical efficacy of neoadjuvant PD-1 blockade against muscle-invasive bladder cancer.

F. Ginhoux, L. Zitvogel, M. Merad, 2022, Cancer discovery.

Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells

N. Weiss, S. Demeret, C. Lebbé, 2022, Frontiers in Immunology.